Safety and Suitability: Is Microdosing Right For Me?

“Micro” describes relative dose, and does not imply guaranteed safety. Even a small amount of a powerful natural medicine can still matter when a person has a vulnerable health history, is taking medication, is pregnant, needs to drive, or cannot step away from responsibilities if the effect is stronger than expected.

Psychosis, Bipolar Disorder, and Other Important Health Considerations

As a general rule, I encourage anyone with significant cardiovascular disease, recent cardiac complications or hospitalizations, or a history of psychotic disorders to approach microdosing cautiously and discuss it with their healthcare provider.

Likewise, if you have bipolar disorder or another serious mental health condition, it’s important to seek guidance from a physician or psychiatrist.

People taking SSRIs and certain other antidepressant medications may also notice little or no effect from microdosing. Because medication interactions and individual health histories vary considerably, it’s another situation where professional guidance is appropriate.

These recommendations aren’t simply my personal opinion. Most clinical psychedelic studies exclude people with a personal or close family history of psychotic disorders and frequently exclude those with bipolar-spectrum conditions as well.

As a result, many of the reassuring findings from those studies can’t automatically be applied to people who weren’t represented in the research. The National Center for Complementary and Integrative Health similarly identifies psychotic disorders and severe forms of bipolar disorder as important safety considerations.

Case reports add another piece to the picture. While they can’t tell us how common an adverse event is, they can highlight serious possibilities that smaller clinical trials may never detect.

Reviews of published case reports have documented episodes of mania and psychosis following psychedelic use. Those reports involved different substances, doses, settings, and underlying health conditions, so they shouldn’t be interpreted as evidence that microdosing carries the same risk for everyone. They do, however, remind us why thoughtful screening and careful preparation matter.

Seizures and neurological history

Seizure risk has not been well characterized because many psychedelic studies exclude people with seizure disorders. A review focused on seizures and classic psychedelics found that evidence is sparse and consists largely of case reports, preclinical work, and limited clinical observations. That is not evidence that microdosing is safe for epilepsy; it is evidence that the question remains unsettled.

A history of seizures, unexplained loss of consciousness, or medication used for seizure control belongs in a high-caution category. The uncertainty itself is material. The earlier guidance in this chapter applies here as well.

Cardiovascular health

Psilocybin can acutely increase heart rate and blood pressure. Most controlled studies involve screening, monitoring, and limited exposure, so they do not answer every question about repeated unsupervised use. The NCCIH safety summary lists increased blood pressure and heart rate among potential adverse effects.

Long-term cardiovascular concern is more theoretical. Some authors have asked whether repeated activation of serotonin receptors—especially 5-HT2B—could create valvular risk over time. A 2025 review of psychedelic “stacks” and cardiovascular considerations discusses the hypothesis, but direct evidence that ordinary psilocybin microdosing causes valvular disease is not established. The concern remains unresolved: neither harm nor safety has been established.

Pregnancy and breastfeeding

Human data on psilocybin use during pregnancy and breastfeeding are inadequate. The MotherToBaby psilocybin fact sheet notes that studies have not established effects on miscarriage, birth defects, pregnancy complications, or breastfeeding. Absence of evidence is not evidence of safety.

Short-term effects and functional impairment

Reported unwanted effects in microdosing research include anxiety, low mood, physical discomfort, gastrointestinal symptoms, headache, sleep disruption, and difficulty focusing. A 2025 systematic review of potential side effects found that available studies are heterogeneous and often short, which limits estimates of frequency and long-term significance.

A microdose isn’t “sub-perceptual” if it interferes with what you’re trying to do. Changes in perception, coordination, reaction time, judgment, attention, or emotional steadiness can impair that task. Driving, operating equipment, caregiving, or other safety-sensitive work while impaired is inappropriate. The Colorado Department of Transportation states plainly that driving while impaired by natural medicine is dangerous and illegal in Colorado.